It acts as a potent agonist of the IGF-1 receptor, activating signaling pathways such as PI3K/Akt and MAPK to promote: Cell Growth and Division : Enhances proliferation in diverse cell lineages, including ectodermal (e.g., oligodendrocytes, motor neurons) and mesodermal (e.g., osteocytes, chondrocytes, muscle cells) types, supporting stem cell research and large-scale biopharmaceutical manufacturing
Similar content being viewed by others Introduction Intestinal neuroendocrine L cells secrete glucagon-like peptides-1 and -2 (GLP-1, GLP-2) and peptide YY (PYY) in response to food ingestion [1, 2, 3, 4, 5, 6]
Maintenance doses vary widelysome patients stabilize at 2.5 mg weekly, others at 7.5 mg or 10 mg
SURMOUNT-MMO [without T2D] in 2027)
Reduced Liver Fat: High doses led to significant reductions in liver fat content, with many participants achieving normal liver fat levels